Skip to content
University of Colorado Anschutz Medical Campus CU Anschutz
  • Webmail
  • UCD Access
  • Canvas
  • Quick Links
 

Tools & Resources

  • Events Calendar
  • Newsroom
  • Strauss Health Sciences Library
  • Department A-Z Directory
  • Campus Directory
  • Leadership
  • Faculty & Staff Resources
  • Supporter & Alumni Resources
  • Student Resources
  • Campus Map
  • University Policies
  • Give Now

CU Campuses

  • CU Anschutz Medical Campus
  • CU Boulder
  • CU Colorado Springs
  • CU Denver
  • CU System
  • CU Online

CU Anschutz Medical Campus

  • School of Dental Medicine
  • Graduate School
  • School of Medicine
  • College of Nursing
  • Skaggs School of Pharmacy and Pharmaceutical Sciences
  • Colorado School of Public Health

Division of Medical Oncology

School of Medicine

  • Home
  • Leadership
    • Division Head | Wells Messersmith, MD, FACP
    • Deputy Division Head | Virginia Borges, MD, MMSc
  • Research
  • Cancer Care
    • CARE Clinic
    • Clinical Trials
    • Find a Provider
    • Satellite Locations
  • Education
  • Giving
  • Newsroom
  • Division Resources
  • Division Directory
    • Clinical & Research Faculty
    • Research Services Personnel
    • Administrative Staff
University Quick Links
  • Home
  • Research
  • Breast Cancer
  • Borges Research Lab

BORGES RESEARCH LAB

Research Focus

Dr. Borges is the educational coordinator for the Division of Medical Oncology, an Associate Program Director for the Internal Medicine Residency and Director of the Internal Medicine Resident Research Program.  Her research centers around clinical breast cancer research including clinical trials with anti-endocrine therapies, novel biologic drug and immunotherapies. The breast research program participates in SWOG, NSABP, RTOG and intergroup studies, of which she is an active member. 

The Borges Lab is focused on the development of novel vaccines and combination immunotherapy for breast cancer and also, though collaborative programs, on potential biologic differences and therapeutic targets for young women's’ breast cancer. 

Virginia Borges, MD, MMSC

Principle Investigator

Michelle Borakove, MS

Research Services Senior Professional

Heather Fairchild, MS

Research Services Professional

Hannah Parris, MPH

Research Services Professional

Elena Shagisultanova, MD, PhD

Clinical Faculty

Selected Publications

Silva CMS, Wanderley CWS, Veras FP, Sonego F, Nascimento DC, Gonçalves AV, Martins TV, Cólon DF, Borges VF, Brauer VS, Damasceno LEA, Silva KP, Toller-Kawahisa JE, Batah SS, Souza ALJ, Monteiro VS, Oliveira AER, Donate PB, Zoppi D, Borges MC, Almeida F, Nakaya HI, Fabro AT, Cunha TM, Alves-Filho JC, Zamboni DS, Cunha FQ. Gasdermin D inhibition prevents multiple organ dysfunction during sepsis by blocking NET formation. Blood. 2021 Dec 23;138(25):2702-2713. doi: 10.1182/blood.2021011525. PMID: 34407544.

Isidro J, Borges V, Pinto M, Sobral D, Santos JD, Nunes A, Mixão V, Ferreira R, Santos D, Duarte S, Vieira L, Borrego MJ, Núncio S, de Carvalho IL, Pelerito A, Cordeiro R, Gomes JP. Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus. Nat Med. 2022 Aug;28(8):1569-1572. doi: 10.1038/s41591-022-01907-y. Epub 2022 Jun 24. Erratum in: Nat Med. 2022 Oct;28(10):2220-2221. PMID: 35750157.

Murthy RK, Loi S, Okines A, Paplomata E, Hamilton E, Hurvitz SA, Lin NU, Borges V, Abramson V, Anders C, Bedard PL, Oliveira M, Jakobsen E, Bachelot T, Shachar SS, Müller V, Braga S, Duhoux FP, Greil R, Cameron D, Carey LA, Curigliano G, Gelmon K, Hortobagyi G, Krop I, Loibl S, Pegram M, Slamon D, Palanca-Wessels MC, Walker L, Feng W, Winer EP. Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer. N Engl J Med. 2020 Feb 13;382(7):597-609. doi: 10.1056/NEJMoa1914609. Epub 2019 Dec 11. Erratum in: N Engl J Med. 2020 Feb 6;382(6):586.  PMID: 31825569.

Lin NU, Borges V, Anders C, Murthy RK, Paplomata E, Hamilton E, Hurvitz S, Loi S, Okines A, Abramson V, Bedard PL, Oliveira M, Mueller V, Zelnak A, DiGiovanna MP, Bachelot T, Chien AJ, O'Regan R, Wardley A, Conlin A, Cameron D, Carey L, Curigliano G, Gelmon K, Loibl S, Mayor J, McGoldrick S, An X, Winer EP. Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial. J Clin Oncol. 2020 Aug 10;38(23):2610-2619. doi: 10.1200/JCO.20.00775. Epub 2020 May 29.  PMID: 32468955.

Full list of publications

      Medical Oncology (SOM)

      CU Anschutz

      Research I South

      12801 East 17th Avenue

      8122

      Aurora, CO 80045


      720-848-0300

      Facebook Twitter
      School
      • School of Medicine Home
      • Find a Doctor
      • Find a Researcher
      • Departments
      • Contact Us
      • Donate
      • School Profiles
      General
      • Affiliate/Partner Hospitals
      • CU Medicine
      • A-Z Index
      • Directory
      • Map and Parking
      • Webmail
      Students
      • Apply Now
      • Alumni
      • Canvas
      • Health Science Library
      • Student Life
      • Colorado Springs Branch
      • Contact Us
      • Website Feedback
      • CU System
      • Privacy Policy
      • Terms of Use
      • Accessibility
      • Accreditation
      • Employment
      • Give Now
       

      © 2023 The Regents of the University of Colorado, a body corporate. All rights reserved.

      Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.

      CMS Login

      Webmail

      UCD Access

      Canvas

      Opens in a new window Opens document in a new window